14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study.
Saved in:
| Title: | 14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study. |
|---|---|
| Authors: | Eng, Virak1 (AUTHOR), Lek, Dysoley2 (AUTHOR), Sin, Sitha1 (AUTHOR), Feufack-Donfack, Lionel Brice1 (AUTHOR), Orban, Agnes1 (AUTHOR), Salvador, Jeremy1 (AUTHOR), Seng, Dynang1 (AUTHOR), Heng, Sokleap1 (AUTHOR), Khim, Nimol1 (AUTHOR), Tebben, Kieran3 (AUTHOR), Flamand, Claude4 (AUTHOR), Sommen, Cecile4 (AUTHOR), van der Pluijm, Rob W5 (AUTHOR), White, Michael5 (AUTHOR), Witkowski, Benoit1 (AUTHOR), Serre, David1,3 (AUTHOR) dserre@som.umaryland.edu, Popovici, Jean1,5 (AUTHOR) jpopovici@pasteur-kh.org |
| Source: | Lancet Infectious Diseases. Aug2025, Vol. 25 Issue 8, p884-895. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
